El interés en corto de Capital Group Global Growth Equity ETF da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Capital Group Global Growth Equity ETF. Los datos de interés en corto se actualizan cada dos semanas.

Capital Group Global Growth Equity ETF (ARCA:CGGO), Informe de interés en corto

Technology

Healthcare

Consumer Cyclical

Industrials

Financial Services

Consumer Defensive

Energy

Basic Materials

Communication Services

Other

The fund invests primarily in common stocks of companies around the world that the investment adviser believes have the potential for growth. The fund normally invests at least 80% of its assets in equity securities. As a fund that seeks to invest globally, the fund will allocate its assets among securities of companies domiciled in various countries, including the United States and countries with emerging markets (but in no fewer than three countries). Under normal market conditions, the fund will invest significantly in issuers domiciled outside the United States (i.e., at least 40% of its net assets, unless market conditions are not deemed favorable by the funds investment adviser, in which case the fund would invest at least 30% of its net assets in issuers domiciled outside the United States).

Microsoft Corp

Taiwan Semiconductor - Adr

Asml Holding Nv

Nvidia Corp.

Novo Nordisk A/S B Common Stock Dkk.1

Alphabet Inc.Class A

Banco Safra S A/Luxembourg

Eli Lilly & Co.

Broadcom Inc

Capital Group Global Growth Equity ETF

Government

News

Regulations

Tech

Media

AAPL

AVEM

Capital Group Global Growth Equity ETF Capital Group Global Growth Equity ETF

CGGO

NVDA

El gobierno de Taiwán estudia medidas para apoyar a Taiwan Semiconductor (TSM) frente a posibles aranceles de Trump.

Taiwán considera apoyos para TSMC ante amenazas arancelarias de Trump

On Tuesday, Paysafe Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) stock fell after its fourth-quarter report.
The company reported quarterly adjusted earnings per share of 48 cents,&nbsp;beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">street view of 24 cents</a>. Quarterly sales of $420.1 million, an increase of 1% year over year, beat the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44104398/paysafe-reports-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">analyst consensus of $429.9 million</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/02/44054285/oktas-growth-in-identity-security-drives-bullish-outlook-analyst-sees-upside" rel="noreferrer noopener">Okta&#8217;s Growth in Identity Security Drives Bullish Outlook, Analyst Sees Upside</a>
Total Payment Volume (TPV) reached $40.0 billion, a 12% increase.
Adjusted EBITDA declined by 15%, or 14% on a constant currency basis, to $103.3 million. Net leverage decreased to 4.7x as of December 31, 2024, compared to 5.0x at year-end 2023.
Revenue from Merchant Solutions rose 1%, reflecting double-digit growth in e-commerce and modest growth from SMBs. This was largely offset by a $10.7 million headwind from the disposed business.
Revenue from Digital Wallets grew 2%, supported by product initiatives that more than offset lower revenue from interest on consumer deposits.
As of December 31, total cash and cash equivalents were $216.7 million, total debt was $2.4 billion, and net debt was $2.1 billion.
FY25 Outlook:&nbsp;Paysafe expects sales of $1.710 billion–$1.734 billion, compared with the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$1.804 billion estimate</a>. It expects&nbsp;adjusted EPS of $2.21-$2.51 against a consensus estimate of $3.04. The company expects an adjusted EBITDA of $463 million-$478 million.
Price Action: PSFE stock is down 8.79% to $17.53 premarket at last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/44053788/alkami-growth-accelerates-with-mantl-deal-boosting-digital-banking-and-cross-sell-potential-analyst-says" target="_blank" rel="noreferrer noopener">Alkami Growth Accelerates With MANTL Deal, Boosts Digital Banking And Cross-Sell Potential: Analyst</a></li>
</ul>

Earnings

Guidance

Movers

PSFE

Paysafe Q4 Revenue Falls Short Despite 12% Payment Volume Growth, Issues Weak 2025 Outlook

LAES

SEALSQ To Acquire IC'Alps; Financial Terms Not Disclosed

Dear Shareholders,
We are pleased to share an update on SEALSQ's financial and strategic progress, highlighting significant advancements that strengthened its balance sheet and positioned the Company for sustained growth. Upcoming Release of SEALSQ's 2024 Audited Financial Results SEALSQ will release its audited 2024 financial results on or before March 21, 2025. This will provide shareholders with a comprehensive overview of our financial performance, operational achievements, and strategic outlook for the year ahead.
A Clean Balance Sheet and Strong Financial Foundation
The robust performance of SEALSQ Ordinary Shares in December 2024 and January 2025 has enabled us to fully eliminate all convertible debt balances and all warrants previously issued in conjunction with the convertible debt. As a result, SEALSQ now has no outstanding warrants containing anti-dilution clauses which can strengthen&nbsp;our ability to attract new investment.&nbsp; By successfully cleaning our balance sheet, we have removed any obligation to secure additional convertible loans, further enhancing our financial flexibility and positioning SEALSQ for a future centered on innovation, strategic growth, and operational excellence.
A $93 Million Sales Opportunities Pipeline Supporting Long-Term Growth
SEALSQ continues to make strides in semiconductor development, PKI, and post-quantum security, reinforcing our leadership in these vital sectors. As we transition toward next-generation quantum-resistant semiconductor technologies, we are strategically positioned to capitalize on industry-wide transformation.
Our robust sales opportunities pipeline of $93 million, on top of clients and projects that we have already won, over the next four years through to the end of 2028 reflects our confidence in the growing demand for SEALSQ solutions. Of these opportunities, over 40 of them relate to our TPM quantum-resistant technology.&nbsp; The increasing adoption of quantum-resistant security technologies will be a key driver of our long-term growth strategy.
Exclusive Agreement to Acquire IC'Alps
In a strategic move to enhance our semiconductor design capabilities, SEALSQ has entered into an exclusivity agreement to acquire IC'Alps, subject only to due diligence and government approval.
IC'Alps' expertise in ASIC design will significantly enhance our ability to deliver state-of-the-art security solutions, expanding both our technological capabilities and market reach. This acquisition aligns with our vision of positioning SEALSQ at the forefront of semiconductor innovation and strengthening our long-term industry leadership.
Pioneering the Future with the SEAL Quantum Roadmap
A major milestone of 2024 was the official launch of the SEAL Quantum Roadmap, setting the stage for our next-generation post-quantum platform and semiconductors.
We anticipate the full rollout of the SEAL Quantum-as-a-Service platform in 2025, eliminating hardware barriers and accelerating the widespread adoption of quantum computing. By fostering collaborations with leading quantum computing companies, we aim to provide customers with access to a cutting-edge security technology ecosystem.
Advancing Quantum-Resistant Security for AI and IoT
The rapid advancement of artificial intelligence (AI) has intensified the demand for robust post-quantum security solutions. SEALSQ's quantum-resistant semiconductors will play a pivotal role in securing AI-driven applications, ensuring:
<ul>
<li>Trusted data exchange</li>
<li>Protection of intellectual property</li>
<li>Compliance with evolving cybersecurity regulations &nbsp;</li>
</ul>
Our secure AI infrastructure will address critical industries, including healthcare, finance, and autonomous systems. Additionally, our collaboration with WISeSat.Space to develop a dedicated satellite-IoT connectivity ecosystem will further strengthen our global presence in IoT security.
Financial Strength and Future Outlook: Cash Reserve of $85 Million at the year end
As of early 2025, SEALSQ had built an unprecedented cash reserve that peaked at over $90 million in January 2025, providing a strong financial foundation to support innovation, operational scalability, and global expansion.
In 2024, we invested $5 million in research and development, underscoring our commitment to pioneering post-quantum security solutions. We anticipate increased revenues from these innovations beginning in 2026.
A Strong Path Forward
Looking ahead, SEALSQ is well-positioned to:
<ul>
<li>Expand its international footprint</li>
<li>Secure additional key partnerships</li>
<li>Scale production capacity</li>
<li>Develop post-quantum ASICs</li>
<li>Strengthen cybersecurity ecosystem &nbsp;</li>
</ul>
We remain fully committed to driving long-term value for our shareholders and executing our vision of securing the digital future through cutting-edge semiconductor and quantum-resistant technologies.
We sincerely appreciate your continued support and confidence as we advance our mission.
Sincerely, Carlos Moreira Chairman &amp; CEO SEALSQ Corp

SEALSQ Releases CEO Letter To Shareholders

WIIM

Target shares are trading lower. The company issued FY26 adjusted EPS guidance with its midpoint below estimates. Additionally, tariff concerns and weakening consumer confidence are weighing on the stock.

Citizens Capital Markets analyst Silvan Tuerkcan reiterates Prime Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) with a Market Outperform and maintains $10 price target.

Price Target

Reiteration

Analyst Ratings

PRME

Citizens Capital Markets Reiterates Market Outperform on Prime Medicine, Maintains $10 Price Target

Scotiabank analyst Patrick Colville maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Sector Perform and raises the price target from $94 to $109.

OKTA

Scotiabank Maintains Sector Perform on Okta, Raises Price Target to $109

TSLA

Tesla shares are trading lower after its China-made EV sales dropped by 49,2% in february. Also, BofA lowered its price target on the stock from $490 to $380.

Citizens Capital Markets analyst Nicholas Jones reiterates Offerpad Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPAD#NYSE">OPAD</a>) with a Market Outperform and maintains $4.5 price target.

OPAD

Citizens Capital Markets Reiterates Market Outperform on Offerpad Solutions, Maintains $4.5 Price Target

Goldman Sachs analyst Lizzie Dove maintains Hilton Grand Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGV#NYSE">HGV</a>) with a Sell and raises the price target from $37 to $42.

Goldman Sachs Maintains Sell on Hilton Grand Vacations, Raises Price Target to $42

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) could be facing mounting pressure as President Donald Trump's administration is considering tightening technology export controls to China, threatening a revenue stream that accounts for roughly 15% of the chipmaker&#8217;s business. 
The potential restrictions respond to recent advances by Chinese AI firms, particularly DeepSeek, whose latest models briefly wiped $600 billion from Nvidia&#8217;s market value earlier this year, <a href="https://www.economist.com/business/2025/02/25/nvidia-is-fighting-both-trump-and-china">the Economist reported last week</a>. 
Commerce Secretary Howard Lutnick signaled a hard-line stance on technology sales to China. During his confirmation hearing, Lutnick pointed to Nvidia&#8217;s chips being used by DeepSeek, saying &#8220;It&#8217;s got to end,&#8221; according to The Economist.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li><a href="https://www.benzinga.com/money/startengine-own">The $1.3 Billion Startup Investment Boom: How This Company's Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum </a></li>
</ul>
The administration is weighing two options that could impact Nvidia&#8217;s business. Officials may further restrict sales of specialized AI chips to China, potentially including the H20, a scaled-down GPU Nvidia created for the Chinese market after previous export controls.
 Dylan Patel, an expert in AI and semiconductor research at SemiAnalysis believes Nvidia has suspended H20 production in anticipation of new restrictions, despite manufacturing over 1 million units in the nine months leading to January, The Economist said. 
The second approach involves enforcing the framework for AI Diffusion, a rule introduced in the final days of the Biden administration to prevent Chinese firms from accessing advanced GPUs through third countries.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share! </a>
Nvidia <a href="https://blogs.nvidia.com/blog/ai-policy/">called the rule</a> &#8220;misguided&#8221; when announced. The company argues that imposing restrictions on over 150 countries risks alienating allies and potentially driving them toward Chinese alternatives like Huawei&#8217;s AI chips. 
Despite the challenges, Nvidia CEO Jensen Huang met with Trump at the White House at the end January. While Huang <a href="https://www.economist.com/business/2025/02/25/nvidia-is-fighting-both-trump-and-china">reportedly</a> lacks the close relationship with Trump that some tech leaders enjoy, he has connections through Elon Musk, whom he praised for building a data center for his GPU-intensive startup xAI. 
Geopolitical tensions have already impacted Nvidia&#8217;s Chinese business, with sales to the region dropping from over 20% of total revenue two years ago. The Chinese government <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42393702/chinese-antitrust-investigation-into-nvidia-all-speculative-tech-expert#:~:text=Chinese%20regulators%20announced%20Monday%20that,trades%2C%20and%20government%20trading%20signals.">has launched an antitrust investigation into Nvidia</a>, widely viewed as retaliation for U.S. export controls.
 See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Nvidia on Wednesday reported quarterly sales <a href="https://www.benzinga.com/markets/equities/25/02/43999126/nvidias-q4-revenue-surges-to-393b-nearly-8x-higher-than-five-years-ago-analysts-debate-stocks-next-move#:~:text=2%20min%20read-,Nvidia's%20Q4%20Revenue%20Surges%20Over%2078%25%2C%20Nearly%208x%20Higher%20Than,Production%20Has%20Been%20Ramped%20Up">growing 78% year-over-year to $39 billion</a>. The company&#8217;s share price has largely recovered from its post-DeepSeek decline, suggesting investors believe the Chinese firm&#8217;s breakthrough might increase GPU demand by making AI more accessible. In a note to clients earlier this week, analysts at TD Cowen highlighted that Microsoft&nbsp; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) <a href="https://www.benzinga.com/25/02/43917474/microsoft-cancels-major-data-center-leases-raises-questions-on-ai-expansion-strategy">canceled some data center leases in America</a>, potentially signaling a slowdown in infrastructure spending, despite the tech giant&#8217;s insistence it remains committed to investing $80 billion in infrastructure this year.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

MSFT

Trump's Tech War Could Cost Nvidia Billions—Here's Why

Target Ceo Says Have Grown Target Plus Into A $1B Plus Dollar Marketplace And It Is Growing In The Double Digits

Scotiabank analyst Kevin Krishnaratne maintains Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) with a Sector Outperform and lowers the price target from $55 to $45.

DCBO

Scotiabank Maintains Sector Outperform on Docebo, Lowers Price Target to $45

AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) has outperformed the market over the past 5 years by 3.61% on an annualized basis producing an average annual return of 19.92%. Currently, AbbVie has a market capitalization of $374.56 billion. 
Buying $1000 In ABBV: If an investor had bought $1000 of ABBV stock 5 years ago, it would be worth $2,381.00 today based on a price of $212.17 for ABBV at the time of writing.
<h3>AbbVie's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741097708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ABBV

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Citizens Capital Markets analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCUL#NASDAQ">OCUL</a>) with a Market Outperform and lowers the price target from $22 to $19.

OCUL

Citizens Capital Markets Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $19

Target shares are trading lower. The company reported Q4 financial results.

<ul>
<li>NVDA</li>
<li>TSLA</li>
<li>WAR</li>
<li>CORN</li>
<li>AMD</li>
<li>EGGS</li>
<li>LUNR</li>
<li>QQQ</li>
<li>GLD</li>
<li>AAPL</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

CORN

Tidal Trust III NestYield Total Return Guard ETF

EGGS

LUNR

Top 10 Trending Stocks On WallStreetBets As Of March 4, 2025 (Via Swaggy Stocks)

Goldman Sachs analyst Matthew Sykes maintains Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) with a Neutral and lowers the price target from $22 to $11.

FTRE

Goldman Sachs Maintains Neutral on Fortrea Holdings, Lowers Price Target to $11

Scotiabank analyst Patrick Colville maintains N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) with a Sector Perform and lowers the price target from $11 to $8.75.

NABL

Scotiabank Maintains Sector Perform on N-able, Lowers Price Target to $8.75

Citizens Capital Markets analyst Matthew Condon reiterates Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) with a Market Outperform and maintains $24 price target.

Citizens Capital Markets Reiterates Market Outperform on Viant Technology, Maintains $24 Price Target

Goldman Sachs analyst Carly Davenport maintains Edison Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) with a Neutral and lowers the price target from $88 to $68.

Comments

Capital Group Global Growth Equity ETF

Interés en corto

Capital Group Global Growth Equity ETF (ARCA:CGGO), Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL